COLINZ

COLINZ LABORATORIES

Small Cap BSE: 531210 NSE: COLINZ
₹38.15
-2 (-4.98%)
As on 14 August, 2022 | 18:21

Colinz Laboratories Share Price

Colinz Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Colinz Laboratories Share Returns

  • Over 1 Month 34.09%
  • Over 3 Month 42.35%
  • Over 6 Month 23.46%
  • Over 1 Year 81.24%

Colinz Laboratories Key Statistics

Colinz Laboratories Investment Rating

  • Master Rating:
  • Colinz Laboratories has an operating revenue of Rs. 6.96 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 7% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -12% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 97 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has great fundamentals and technical strength to stay in momentum. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Colinz Laboratories Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • Operating Expenses Qtr Cr
  • 2
  • 1
  • 1
  • 2
  • 2
  • 2
  • Operating Profit Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Depreciation Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0

Colinz Laboratories Technicals

EMA & SMA

Current Price
38.15
-2 (-4.98%)
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • 39.03
  • 50 Day
  • 34.15
  • 100 Day
  • 31.02
  • 200 Day
  • 27.73
  • 20 Day
  • 39.02
  • 50 Day
  • 31.75
  • 100 Day
  • 29.52
  • 200 Day
  • 27.71

Colinz Laboratories Resistance and Support

PIVOT
₹41.42
Resistance
  • First Resistance
  • 42.69
  • Second Resistance
  • 45.22
  • Third Resistance
  • 46.49
Support
  • First Resistance
  • 38.89
  • Second Resistance
  • 37.62
  • Third Resistance
  • 35.09
  • RSI
  • 51.68
  • MFI
  • 63.98
  • MACD Single Line
  • 3.84
  • MACD
  • 3.2

Colinz Laboratories Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 2,852
  • 285,200
  • 100
  • Week
  • 7,367
  • 736,675
  • 100
  • 1 Month
  • 5,057
  • 505,743
  • 100
  • 6 Month
  • 1,665
  • 166,480
  • 100

Colinz Laboratories Result Highlights

Colinz Laboratories Synopsis

BSE-Medical-Generic Drugs

Colinz Laborator belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 6.16 Cr. and Equity Capital is Rs. 3.55 Cr. for the Year ended 31/03/2021. Colinz Laboratories Ltd. is a Public Limited Listed company incorporated on 06/10/1986 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1986PLC041128 and registration number is 041128.
  • Market Cap
  • 10
  • Sales
  • 7
  • Shares in Float
  • 0.09
  • No of funds
  • 1
  • Yield
  • Book Value
  • 1.76
  • U/D Vol ratio
  • 2.2
  • LTDebt / Equity
  • Alpha
  • 0.29
  • Beta
  • 0.53

Colinz Laboratories

  • Owner Name
  • Jun-22
  • Apr-22
  • Mar-22
  • Dec-21
  • Promoters
  • 66.01%
  • 66.01%
  • 36.38%
  • Financial Institutions/ Banks
  • 0.12%
  • 0.12%
  • 0.07%
  • Individual Investors
  • 31.81%
  • 31.83%
  • 59.92%
  • Others
  • 2.06%
  • 2.04%
  • 3.63%

Colinz Laboratories Management

  • Name
  • Designation
  • Mr. N K Menon
  • Whole Time Director
  • CA. Vasant K Bhat
  • Independent Director
  • Mr. A Krishna Kumar
  • Independent Director
  • Dr. Mani L S
  • Director

Colinz Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Colinz Laboratories Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-30
  • Quarterly Results
  • 2022-05-28
  • Audited Results
  • 2022-04-15
  • Others
  • Inter alia to consider and approve forfeiture of partly paid up equity shares of the Company on which the call money is pending as on 1st April,2022.
  • 2022-01-31
  • Quarterly Results
  • 2021-10-30
  • Quarterly Results

Colinz Laboratories FAQs

What is Share Price of Colinz Laboratories ?

Colinz Laboratories share price is ₹38 As on 14 August, 2022 | 18:07

What is the Market Cap of Colinz Laboratories ?

The Market Cap of Colinz Laboratories is ₹9.6 Cr As on 14 August, 2022 | 18:07

What is the P/E ratio of Colinz Laboratories ?

The P/E ratio of Colinz Laboratories is 26.3 As on 14 August, 2022 | 18:07

What is the PB ratio of Colinz Laboratories ?

The PB ratio of Colinz Laboratories is 1.3 As on 14 August, 2022 | 18:07

Q1FY23